Half Year 2025 RTW Biotech Opportunities Ltd Earnings Call Transcript
Hello, everyone, and thank you for taking the time to join the presentation of RTW Bio's half year results till the June 30. 2025. I'm Woody Stileman, Head of the London Office of RTW, and I'm joined by the Founder and CIO of RTW Investments, Rod Wong, who's based in New York. We have lots of news to share, and I'd encourage you to submit any questions via e-mail to [email protected], and we'll address these following the results presentation.
Before we get into the results and the exciting developments within our portfolio, I wanted to take a step back and remind you of who we are. In Biotech, innovation is a core driver of long-term value creation. Innovation expands the opportunity set and unlocks new treatments, cures and revenue streams. We and others believe that the pace of innovation is accelerating at an unprecedented rate. And what makes this particularly compelling is a high alpha potential.
The asymmetric return profile in this space means that a small number of successful
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
